Clinical Oncology: Year 2019 in Review

The clinical practice of oncology is a rapidly-evolving discipline. This program will provide physicians – especially oncologists, gynecologic oncologists, hematologists, radiation oncologists, and surgical oncologists – as well as cancer-interested dermatologists, gastroenterologists, nephrologists, pulmonologists, urologists, nurse practitioners and physician assistants, with a summary of the latest advances in discipline-related cancers. New therapeutic agents will be a topic of discussion. This program will focus on how these new advances will impact the practice of oncology today.


Updates in the Management of Breast Cancer

Shipra Gandhi, MD, provides updates on neoadjuvant, adjuvant and metastatic therapies for the treatment of HER2-positive breast cancer, hormone receptor positive breast cancer, and triple negative breast cancer.
Shipra Gandhi, MD

Shipra Gandhi, MD

Assistant Professor of Oncology
Breast and Early Phase Clinical Trials, Department of Medicine

Updates in the Management of GI Malignancies

Christos Fountzilas, MD, discusses updates in GI malignancies. This lecture covers esophagogastric cancer, pancreatic cancer, colorectal cancer, neuroendocrine tumors, hepatocellular carcinoma and cholangiocarcinoma.
Christos Fountzilas, MD

Christos Fountzilas, MD

Assistant Professor of Oncology
Department of Medicine, GI Center

New Drugs and Promising Combinations

Out of the many of new drugs in development, Igor Puzanov, MD, MSCI, FACP, selected those that seem the most promising. In this lecture he will discuss the novel classes of promising agents in development, how to enhance immune response ...
Igor Puzanov, MD, MSCI, FACP

Igor Puzanov, MD, MSCI, FACP

Senior Vice President, Clinical Investigation
Professor of Oncology, Department of Medicine
Director, Center for Early Phase Clinical Trials
Chief, Early Phase Clinical Trials Division
Chief, Melanoma Section

Updates in Lung Cancer Treatments

Edwin Yau, MD, PhD, discusses metastatic lung cancers and provides updates on new FDA approvals.
Edwin Yau, MD, PhD

Edwin Yau, MD, PhD

Assistant Professor of Oncology
Department of Medicine
Department of Cancer Genetics & Genomics